Firefly Neuroscience (AIFF) Cash from Investing Activities Growth (5y) (2015 - 2026)
Powered by 
Analysis
Firefly Neuroscience (AIFF) Cash from Investing Activities Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.90% |
| Mar 31, 2026 | -65.92% |
| Dec 31, 2025 | -31.24% |
| Sep 30, 2025 | -11.53% |
| Sep 30, 2024 | -211.47% |
| Jun 30, 2024 | -120.65% |
| Dec 31, 2023 | -196.10% |
| Sep 30, 2023 | -280.53% |
| Mar 31, 2023 | 290.43% |
| Dec 31, 2022 | -433.26% |
| Sep 30, 2022 | -208.07% |
| Jun 30, 2022 | -86.52% |
| Mar 31, 2022 | -50.36% |
| Dec 31, 2021 | -508.10% |
| Sep 30, 2021 | -105.21% |
| Jun 30, 2021 | -326.16% |
| Mar 31, 2021 | 18.27% |
| Dec 31, 2020 | 4.67% |
| Sep 30, 2020 | -99.10% |
| Dec 31, 2019 | 37.20% |